Paper40902196
Molecular Docking and Target-Specific Binding Profiles of Benzosuberane-Based Compounds.
Saragatsis MA and 3 others. ChemMedChem, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Molecular Docking and Target-Specific Binding Profiles of Benzosuberane-Based Compounds. Papers, record 40902196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40902196
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Molecular Docking Simulation | Major topic |
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Cell Proliferation | |
| Molecular Structure | |
| Structure-Activity Relationship |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PB04565 | Technological University Dublin | PubMed |
Source PubMed
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31417185 | MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma. | Oncogene | 2019 | https://conductscience.org/library/papers/31417185 | PubMed |
| 2 | 22114500 | A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapy. | Int J Nanomedicine | 2011 | https://conductscience.org/library/papers/22114500 | PubMed |
| 3 | 28383176 | Insight into the remarkable affinity and selectivity of the aminobenzosuberone scaffold for the M1 aminopeptidases family based on structure analysis. | Proteins | 2017 | https://conductscience.org/library/papers/28383176 | PubMed |
| 4 | 35890113 | Synthesis, Structure−Activity Relationships, and Parasitological Profiling of Brussonol Derivatives as New Plasmodium falciparum Inhibitors | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/35890113 | PubMed |
| 5 | 29455642 | Role and targeting of anaplastic lymphoma kinase in cancer. | Mol Cancer | 2018 | https://conductscience.org/library/papers/29455642 | PubMed |
| 6 | 34483651 | Machine Learning and Deep Learning Based Computational Approaches in Automatic Microorganisms Image Recognition: Methodologies, Challenges, and Developments. | Arch Comput Methods Eng | 2022 | https://conductscience.org/library/papers/34483651 | PubMed |
| 7 | 31592646 | Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets. | J Med Chem | 2020 | https://conductscience.org/library/papers/31592646 | PubMed |
| 8 | 14716737 | Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. | Prostate | 2004 | https://conductscience.org/library/papers/14716737 | PubMed |
| 9 | 25618350 | Small-molecule library screening by docking with PyRx. | Methods Mol Biol | 2015 | https://conductscience.org/library/papers/25618350 | PubMed |
| 10 | 32183020 | The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32183020 | PubMed |
| 11 | 25625291 | Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitors. | Cancers (Basel) | 2015 | https://conductscience.org/library/papers/25625291 | PubMed |
| 12 | 22564207 | Discovery of an orally efficacious inhibitor of anaplastic lymphoma kinase. | J Med Chem | 2012 | https://conductscience.org/library/papers/22564207 | PubMed |
| 13 | 34278794 | AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. | J Chem Inf Model | 2021 | https://conductscience.org/library/papers/34278794 | PubMed |
| 14 | 26529257 | Myo9b is a key player in SLIT/ROBO-mediated lung tumor suppression. | J Clin Invest | 2015 | https://conductscience.org/library/papers/26529257 | PubMed |
| 15 | 12925999 | Detailed analysis of grid-based molecular docking: A case study of CDOCKER-A CHARMm-based MD docking algorithm. | J Comput Chem | 2003 | https://conductscience.org/library/papers/12925999 | PubMed |
| 16 | 28934959 | Selective inhibition of PfA-M1, over PfA-M17, by an amino-benzosuberone derivative blocks malaria parasites development in vitro and in vivo. | Malar J | 2017 | https://conductscience.org/library/papers/28934959 | PubMed |
| 17 | 31784318 | Development and structure-activity relationship study of SHP2 inhibitor containing 3,4,6-trihydroxy-5-oxo-5H-benzo[7]annulene. | Bioorg Med Chem Lett | 2020 | https://conductscience.org/library/papers/31784318 | PubMed |
| 18 | 24349632 | Role of p38 MAP Kinase Signal Transduction in Solid Tumors. | Genes Cancer | 2013 | https://conductscience.org/library/papers/24349632 | PubMed |
| 19 | 21321746 | A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment. | Integr Biol (Camb) | 2011 | https://conductscience.org/library/papers/21321746 | PubMed |
| 20 | 36058118 | Novel 6,7,8-trihydrobenzo[6',7']cyclohepta[2',1'-e]pyrazolo[2,3-a]pyrimidine derivatives as Topo IIα inhibitors with potential cytotoxic activity. | Bioorg Chem | 2022 | https://conductscience.org/library/papers/36058118 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42655636 | Human Coronavirus Photodynamic Inactivation and In Silico Mechanisms Induced by Ga(III) vs. Zn(II) Phthalocyanines. | Viruses | 2026 | https://conductscience.org/library/papers/42655636 | PubMed |
| 42458892 | Recent Overview on the Molecular Hybrids Integrated With Benzosuberone/Benzo[7]annulene Derivatives as Multi-Target Therapeutics. | Arch Pharm (Weinheim) | 2026 | https://conductscience.org/library/papers/42458892 | PubMed |
| 41821758 | A comparison of honeybee and scorpion venoms as anticancer agents against three different cancer cell lines: lung, colon, and breast cancer. | Front Toxicol | 2026 | https://conductscience.org/library/papers/41821758 | PubMed |
| 40902196 | Molecular Docking and Target-Specific Binding Profiles of Benzosuberane-Based Compounds. | ChemMedChem | 2025 | https://conductscience.org/library/papers/40902196 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40902196
GET https://conductscience.org/api/papers/v1/40902196/references?page=2